title: RAS-Mediated Adaptive Mechanisms in Cardiovascular Tissues: Confounding Factors of RAS Blockade Therapy and Alternative Approaches.
abstract: Since the classic experiments by Tigerstedt and Bergman that established the role of renin in hypertension a century ago, aggressive efforts have been launched to effectively block the renin-angiotensin system (RAS). Blockade of RAS is advocated at multiple levels by direct renin inhibitor, angiotensin-converting enzyme inhibitor and/or angiotensin II type 1 receptor blocker, or aldosterone inhibitor (spironolactone), and has now become part of the standard of care to control hypertension and related metabolic diseases including diabetes. However, recent lessons learned from randomized clinical trials question the wisdom of blocking RAS at multiple levels. In this context, it is highly pertinent that components of RAS are evolutionarily conserved, and novel physiological/adaptive/protective roles for renin and angiotensin-converting enzyme are currently emerging. Angiotensin II, the classical RAS effector peptide responsible for hypertension, hypertrophy, fluid retention and fibrosis, manifests its cardiovascular protective effect when it activates the angiotensin II type 2 receptor. Additionally, angiotensin-converting enzyme 2 and the angiotensin II metabolite Ang-(1-7) that acts through the Mas proto-oncogene constitute the cardiovascular and renal protective branch of RAS. It is conceivable that modulating this vasodilative/anti-inflammatory branch of RAS by activation of the RAS components that constitute this branch may offer a safer long-term treatment strategy to balance RAS activity and achieve homeostasis compared to chronic multilevel RAS inhibition.
authors: Department of Internal Medicine, University of Missouri School of Medicine, Columbia, Mo., USA ; Diabetes and Cardiovascular Research Center, University of Missouri School of Medicine, Columbia, Mo., USA ; Harry S Truman Veterans Affair Medical Center, University of Missouri, Columbia, Mo., USA.
authors: Rukhsana
authors: R
authors: Gul
authors: Maya
authors: M
authors: Ramdas
authors: Chirag H
authors: CH
authors: Mandavia
authors: James R
authors: JR
authors: Sowers
authors: Lakshmi
authors: L
authors: Pulakat
references: Hum Mutat. 2012 Feb;33(2):316-26
references: 22095942
references: Cardiol Rev. 2011 Nov-Dec;19(6):300-4
references: 21983318
references: J Clin Invest. 2010 Apr;120(4):1229-39
references: 20335663
references: Cell Physiol Biochem. 2009;24(1-2):45-52
references: 19590192
references: J Biol Chem. 2011 Jun 3;286(22):19880-91
references: 21502318
references: J Mol Med (Berl). 2010 Oct;88(10):993-1001
references: 20725711
references: Ann Intern Med. 2009 May 19;150(10):717-24
references: 19451579
references: Obes Rev. 2012 Feb;13(2):136-49
references: 22034852
references: N Engl J Med. 2008 Apr 10;358(15):1547-59
references: 18378520
references: J Surg Res. 2011 May 15;167(2):e63-9
references: 20189597
references: Circulation. 2011 Mar 15;123(10):1098-107
references: 21357827
references: Hypertens Res. 2012 Jun;35(6):604-10
references: 22318205
references: Hypertension. 2011 Mar;57(3):577-85
references: 21242463
references: Eur J Biochem. 1996 Aug 1;239(3):558-65
references: 8774697
references: Circulation. 2008 Jun 24;117(25):3199-205
references: 18559696
references: Circ Res. 1995 Dec;77(6):1070-6
references: 7586218
references: Endocrinology. 2012 Mar;153(3):1411-20
references: 22234465
references: Eur J Heart Fail. 2012 Apr;14(4):341-3
references: 22431404
references: Hypertension. 2011 Jun;57(6):1069-75
references: 21536989
references: Nephrol Dial Transplant. 2011 Sep;26(9):2827-47
references: 21372254
references: Hypertension. 2001 Dec 1;38(6):1246-9
references: 11751697
references: Hypertension. 2010 Feb;55(2):445-52
references: 20026757
references: Curr Diabetes Rev. 2011 Jan;7(1):3-7
references: 21067505
references: Lancet. 2008 Aug 16;372(9638):547-53
references: 18707986
references: Hypertension. 2012 Feb;59(2):300-7
references: 22184331
references: Physiol Rev. 1998 Jul;78(3):583-686
references: 9674690
references: J Renin Angiotensin Aldosterone Syst. 2012 Mar;13(1):217-9
references: 22389391
references: Am J Hypertens. 2012 Aug;25(8):839-47
references: 22237158
references: Exp Physiol. 2012 Jan;97(1):89-101
references: 21967903
references: J Am Soc Nephrol. 2005 Jan;16(1):125-32
references: 15563565
references: FEBS Lett. 2002 Dec 18;532(3):379-86
references: 12482596
references: J Hypertens. 2012 May;30(5):1029-40
references: 22441345
references: Hum Mol Genet. 2011 Jan 15;20(2):301-11
references: 21036942
references: J Gen Intern Med. 2012 Jun;27(6):716-29
references: 22147122
references: Hypertension. 2011 Mar;57(3):614-9
references: 21242461
references: J Renin Angiotensin Aldosterone Syst. 2005 Dec;6(3):121-31
references: 16525942
references: Am J Physiol Renal Physiol. 2010 Jan;298(1):F37-48
references: 19846569
references: Trends Endocrinol Metab. 2010 Nov;21(11):684-90
references: 20889352
references: Bioorg Med Chem Lett. 2011 Sep 15;21(18):5487-92
references: 21840215
references: J Renin Angiotensin Aldosterone Syst. 2010 Mar;11(1):7-17
references: 19759061
references: Hypertension. 2012 Aug;60(2):387-95
references: 22689743
references: Hypertension. 2010 Feb;55(2):207-13
references: 20038757
references: Nature. 2010 Nov 4;468(7320):108-11
references: 20927107
references: Br J Pharmacol. 2012 Mar;165(6):2000-2008
references: 22014125
references: J Am Soc Nephrol. 2011 Dec;22(12):2237-46
references: 22052052
references: Metabolism. 2009 May;58(5):708-13
references: 19375596
references: Hypertens Res. 2010 Oct;33(10):1044-52
references: 20668453
references: Hypertens Res. 2009 Jul;32(7):533-6
references: 19461648
references: Eur J Pharmacol. 2004 Jun 16;493(1-3):161-5
references: 15189777
references: Am J Respir Crit Care Med. 2010 Oct 15;182(8):1065-72
references: 20581171
references: Curr Opin Nephrol Hypertens. 2012 Mar;21(2):142-6
references: 22257799
references: Physiol Genomics. 2010 Aug;42(3):437-44
references: 20501694
references: Circ Heart Fail. 2011 Nov;4(6):770-8
references: 21835984
references: Cardiovasc Drugs Ther. 2013 Apr;27(2):145-53
references: 22392185
references: Circ Res. 2004 Jul 9;95(1):9-20
references: 15242981
references: Kidney Int. 2011 Nov;80(9):911-914
references: 21997507
references: J Mol Cell Cardiol. 2004 Jun;36(6):781-9
references: 15158118
references: Am J Nephrol. 2010;32(1):83-94
references: 20551626
references: J Pharmacol Exp Ther. 2010 Dec;335(3):572-9
references: 20801892
references: Am J Physiol Regul Integr Comp Physiol. 2011 Oct;301(4):R885-95
references: 21813874
references: Cell Signal. 2005 Mar;17(3):395-404
references: 15567070